Subscribe for the newsletter
Sign in
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
IssueQ22022
Sort By
Newest First
1 / 3
1 / 3
Cell Line Development
Integrating Cell Line and CMC Development
Stephen Hamilton, Ph.D.; Mike Brem
Wheeler Bio
PAO-06-022-CL-12
September 02, 2022
ADCS
Improving the Therapeutic Index of ADCs with a Peptide Linker Technology
Philipp Spycher
Araris Biotech
PAO-07-022-CL-01
July 07, 2022
Column: Clinical Trials
CAR-T Study Shines New Spotlight on Clinical Trials Representation
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-06
July 02, 2022
Column: M&A
Who's Left to Acquire in CDMO Biomanufacturing? A Select Few.
Nigel Walker
Nice Insight
PAO-06-022--NI-12
June 24, 2022
Column: New Drug Watch
New Drug Watch: A Validation of the ‘Twincretin’ Approach to Type 2 Diabetes
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-08
June 24, 2022
Column: Investment
IPOs Have Not Recovered In 2022. When Will Biotech Bounce Back?
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-02
June 24, 2022
Column: Regulatory Spotlight
The Price of Pain: Acknowledging a Crisis and Encouraging an Alternative
David Alvaro, Ph.D.
Pharma's Almanac
PAO-06-022--NI-05
June 24, 2022
NFTs
Digital Frontiers: What NFTs Can Do for Pharma
Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-01
June 24, 2022
Column: Supply Chain
Creating a More Resilient Pharmaceutical Supply Chain One Segment at a Time
Tonia Becker
Nice Insight
PAO-06-022--NI-09
June 24, 2022
Mental Health
Mental Health During a Global Pandemic
Marc Technow
Nice Insight
PAO-06-022--NI-03
June 24, 2022
Biotechs
10 More Biotechs Making Moves in 2022
David Alvaro, Ph.D.; Danielle Alvarez
Pharma's Almanac
PAO-06-022--NI-07
June 24, 2022
Cell Therapy
Taking Adoptive Cell Therapies to the Next Level
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-04
June 24, 2022
Unmet Needs
In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?
Pharma's Almanac
PAO-06-022--RT-01
June 24, 2022
Industry Challenges
What do you consider the biggest challenge that the pharma/biopharma industry currently faces?
Pharma's Almanac
O-06-022--RT-01
June 24, 2022
Quantum Computing
Quantum Computing will Transform Drug Discovery, Development, Manufacturing, and Supply Chain Management
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-06-022--NI-10
June 24, 2022
API
Small Molecule API Market Trends
James Grote
Nice Insight
PAO-06-022--NI-11
June 24, 2022
Real-World Data
Real-World Data and Artificial Intelligence are Transforming Clinical Development
Jeff Elton, Ph.D.
ConcertAI
PAO-06-022-CL-09
June 21, 2022
Cell and Gene Therapy Analytics
Accelerating the Development of High-Quality Cell and Gene Therapies with Comprehensive, In-house Analytical Support
Hui Chen, Ph.D.
Porton Advanced Solutions
PAO-06-022-CL-07
June 21, 2022
Rare Diseases
Staying Agile to Bring Therapies to Patients with Rare Diseases
Sheila Frame
Amryt Pharma
PAO-06-022-CL-08
June 21, 2022
Immuno-Oncology
Tuning the Myeloid Compartment with a Best-in-Class CDMO
Kiren Khanduga; Alicia Levey, Ph.D.
Pionyr Immunotherapeutics
PAO-06-022-CL-04
June 06, 2022
